HAV/HBV Vaccines
"Vaccines for Hepatitis A and B - The Latest Recommendations on Safe and Extended Protection."
Published in Hepatitis Weekly, February 2nd, 1998
According to the author's abstract of an article published in Postgraduate Medicine, "Hepatitis A vaccines (Havrix and Vaqta), administered in two doses, provide long-term protection. Target groups include international travelers, children in high-risk communities, homosexually active men, injecting drug users, persons who work with nonhuman primates, patients with chronic hepatitis, and recipients of clotting factors. The place of hepatitis A vaccination in the childhood-immunization schedule has not been determined. Postexposure prophylaxis for hepatitis A consists of administration of immune globulin within 2 weeks of exposure. Hepatitis B vaccines (Recombivax HE and Engerix-B),...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1998-02-02)
More Articles from Hepatitis Weekly
- Risk Factors (HGV)
Drinking, Transfusions Linked to Hepatitis G Infection - At-Risk Populations (HAV)
Outbreak Among Gay Australians Underscores Vaccination Need - Carcinogenesis
Senescent Human Protein May Explain HBV-Linked Cancer - Quality of Life (HCV)
"Asymptomatic Infection" May Be Misnomer in Hepatitis C - Therapy (HCV)
NS5A Mutation Doesn't Predict IFN Response in Children - Blood Banking (Hepatitis G Virus)
No HGV RNA Detected in Blood Used for Transfusion - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
